Glenmark receives tentative ANDA approval for Calcipotriene & Betamethasone Dipropionate Foam General Announcement Filing viewer · member access Original SGX announcement
Settlement and delisting General Announcement Filing viewer · member access Original SGX announcement
Glenmark receives the India Pharma Innovation of the Year Award from the Government of India General Announcement Filing viewer · member access Original SGX announcement
Glenmark becomes the First Pharmaceutical Company to launch Teneligliptin and Pioglitazone General Announcement Filing viewer · member access Original SGX announcement
Intimation regarding Notice of Postal Ballot General Announcement Filing viewer · member access Original SGX announcement
Glenmark Specialty S.A. receives approval for conducting Clinical Trial of its Novel Molecule General Announcement Filing viewer · member access Original SGX announcement
Outcome of the Board Meeting held on 7th April, 2022 General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals receives ANDA approval for Lacosamide Tablets USP General Announcement Filing viewer · member access Original SGX announcement
Glenmark inks agreement with Astrazeneca to commercialize its product Pulmicort Respules in Columbia General Announcement Filing viewer · member access Original SGX announcement
Third Quarter Results Financial Statements and Related Announcement Filing viewer · member access Original SGX announcement
Glenmark launches Nitric Oxide Nasal Spray (FabiSpray) in India General Announcement Filing viewer · member access Original SGX announcement
Board Meeting Intimation General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals receives ANDA approval for Bisoprolol Fumarate & Hydrochlorothiazide Tablet General Announcement Filing viewer · member access Original SGX announcement
Glenmark Specialty S.A. and Lotus International Pte. Ltd. enter into Exclusive Licensing Agreement General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals receives ANDA tentative approval for Regadenoson Injection General Announcement Filing viewer · member access Original SGX announcement
Glenmark Specialty S.A. receives NDA Approval by the US FDA for Ryaltris Nasal Spray General Announcement Filing viewer · member access Original SGX announcement
Regulation 30 of SEBI (LODR) Regulations, 2015 CRISIL Ratings General Announcement Filing viewer · member access Original SGX announcement
Glenmarks subsidiary,lchnos Sciences and Almirall enter into an exclusive Licensing Agreement General Announcement Filing viewer · member access Original SGX announcement
Glenmark makes it to the prestigious Dow Jones Sustainability Emerging Markets Index General Announcement Filing viewer · member access Original SGX announcement
Half Yearly Results Financial Statements and Related Announcement Filing viewer · member access Original SGX announcement
Board Meeting Intimation General Announcement Filing viewer · member access Original SGX announcement